Overview
Hyatt Degreen is an Oncologist practicing medicine in Lancaster, Pennsylvania.
Dr. Degreen is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Pleuropulmonary Blastoma.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1858 Charter Ln Ste 202, Lancaster, PA 17601
University Of Pennsylvania
Jakub Svoboda is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Svoboda is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Classical Hodgkin Lymphoma, B-Cell Lymphoma, and Bone Marrow Aspiration.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Frequently Asked Questions about Dr. Hyatt P. Degreen
How do I make an appointment with Dr. Hyatt P. Degreen?
You can book an appointment with Dr. Hyatt P. Degreen by calling their office at 717-291-1313. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hyatt P. Degreen a top-rated expert for Chronic B-Cell Leukemia (CBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hyatt P. Degreen is classified as an Advanced expert for Chronic B-Cell Leukemia (CBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hyatt P. Degreen specialize in?
While Dr. Hyatt P. Degreen is a Oncology, they have specific expertise in Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Hyatt P. Degreen accept my insurance?
Dr. Hyatt P. Degreen accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 717-291-1313 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic B-Cell Leukemia (CBCL)Dr. Degreen isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Degreen isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Richter SyndromeDr. Degreen isAdvanced. Learn about Richter Syndrome.
- Experienced
- AstrocytomaDr. Degreen isExperienced. Learn about Astrocytoma.
- Colorectal CancerDr. Degreen isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Degreen isExperienced. Learn about Familial Colorectal Cancer.
- Follicular LymphomaDr. Degreen isExperienced. Learn about Follicular Lymphoma.
- Lung CancerDr. Degreen isExperienced. Learn about Lung Cancer.
- Lynch SyndromeDr. Degreen isExperienced. Learn about Lynch Syndrome.
- Metastatic Brain TumorDr. Degreen isExperienced. Learn about Metastatic Brain Tumor.
- Multiple MyelomaDr. Degreen isExperienced. Learn about Multiple Myeloma.
- OligodendrogliomaDr. Degreen isExperienced. Learn about Oligodendroglioma.
- Pleuropulmonary BlastomaDr. Degreen isExperienced. Learn about Pleuropulmonary Blastoma.
- Smoldering Multiple MyelomaDr. Degreen isExperienced. Learn about Smoldering Multiple Myeloma.
